STAPHYLOCOCCUS SP - ANVISA Registration 81062710035

Access comprehensive regulatory information for STAPHYLOCOCCUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710035 and manufactured by CEPHEID. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 19, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including CEPHEID, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81062710035
2 Related Devices
Registration Details
ANVISA Registration Number: 81062710035
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Xpert MRSA NxG
Risk Class III

Registration Details

81062710035

25351451519201911

18628083000123

Company Information

CEPHEID
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Aug 19, 2019

19/08/2029

09/18/2025 19:00:01

Xpert MRSA NxG
Risk Class III

Registration Details

81062710035

25351451519201911

18628083000123

Dates and Status

Aug 19, 2019

19/08/2029

09/18/2025 19:00:01